These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm. Zhang X; Sun J; Yang M; Wang L; Jin J Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682 [TBL] [Abstract][Full Text] [Related]
3. A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm. Ceribelli M; Hou ZE; Kelly PN; Huang DW; Wright G; Ganapathi K; Evbuomwan MO; Pittaluga S; Shaffer AL; Marcucci G; Forman SJ; Xiao W; Guha R; Zhang X; Ferrer M; Chaperot L; Plumas J; Jaffe ES; Thomas CJ; Reizis B; Staudt LM Cancer Cell; 2016 Nov; 30(5):764-778. PubMed ID: 27846392 [TBL] [Abstract][Full Text] [Related]
4. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm. Sukswai N; Aung PP; Yin CC; Li S; Wang W; Wang SA; Ortega V; Lyapichev K; Nagarajan P; Alfattal R; Angelova E; Tang Z; Loghavi S; Kanagal-Shamanna R; Miranda RN; Pemmaraju N; Bhalla K; Konopleva M; Medeiros LJ; Khoury JD Am J Surg Pathol; 2019 Oct; 43(10):1429-1437. PubMed ID: 31261288 [TBL] [Abstract][Full Text] [Related]
5. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches. Cheng W; Yu TT; Tang AP; He Young K; Yu L Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354 [TBL] [Abstract][Full Text] [Related]
6. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells. Wu SJ; Sadigh S; Lane AA; Pinkus GS Am J Clin Pathol; 2023 May; 159(5):455-463. PubMed ID: 36880313 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological analysis of 46 cases with CD4 Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410 [TBL] [Abstract][Full Text] [Related]
8. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy. Riaz W; Zhang L; Horna P; Sokol L Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209 [TBL] [Abstract][Full Text] [Related]
11. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy. Wilson NR; Konopleva M; Khoury JD; Pemmaraju N Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167 [TBL] [Abstract][Full Text] [Related]
12. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies. Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248 [TBL] [Abstract][Full Text] [Related]
13. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality. Sumarriva Lezama L; Chisholm KM; Carneal E; Nagy A; Cascio MJ; Yan J; Chang CC; Cherry A; George TI; Ohgami RS Histopathology; 2018 Nov; 73(5):767-776. PubMed ID: 29884995 [TBL] [Abstract][Full Text] [Related]
14. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response. Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm. Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050 [TBL] [Abstract][Full Text] [Related]
16. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder. Patel JL; Shetty S; Salama ME Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710 [TBL] [Abstract][Full Text] [Related]
17. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body. Cui XB; Jin J; Pang XL; Li S; Liu CX; Li TT; Peng H; Zhang SM; Li L; Liang WH; Chen YZ; Li F Int J Clin Exp Pathol; 2014; 7(7):4391-9. PubMed ID: 25120824 [TBL] [Abstract][Full Text] [Related]
18. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review. Ding Y; Yang J; Lindsey K Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895 [TBL] [Abstract][Full Text] [Related]